Titan Pharmaceuticals, Inc. Announces Closing of Merger with Black Titan Corporation
TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP
URGENT: The M&A Class Action Firm Encourages $hareholders to Act Before Vote – Titan Pharmaceuticals, Inc. (Nasdaq: TTNP)
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
North American Morning Briefing : Global Ad Shares -2-
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Titan Pharmaceuticals, Inc. – TTNP
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Titan Pharmaceuticals, Inc. - TTNP
Shareholder Alert: Ademi LLP investigates whether Titan Pharmaceuticals, Inc. has obtained a Fair Price for its Public Shareholders
TTNP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Titan Pharmaceuticals, Inc. Is Fair to Shareholders
Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.
Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors
Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock
Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets
Which Industries Are Penny Stocks Investors Watching Right Now
What to Know About Buying Penny Stocks on July 8th
Penny Stocks To Watch: Why KRKR, RMED, TYME, TTNP & ENDP Stock Are Moving
Titan Pharmaceuticals Raises $5.5M Via Equity
Titan Announces Positive Results from the First Studies of TP-2021 Implant in an Established Animal Model of Chronic Pruritus
Titan Pharmaceuticals Announces Filing Of 2020 Annual Report On Form 10-K
TTNP Stock Price Increases Over 15% Pre-Market: Why It Happened
Positive Early Study Results Help Pave Wave for Titan Pharmaceuticals to Move Forward with its JT-09 ProNeura® Development Program
Titan Pharmaceuticals Announces Pricing of $9.7 Million Registered Direct Offering
Titan Pharmaceuticals Announces Reverse Stock Split
TTNP Stock Price Increases 34.75%: Why It Happened
Titan Pharmaceuticals Reports Third Quarter 2020 Financial Results
7 Penny Stocks to Watch in November
Titan Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering
Titan Pharmaceuticals News: 8 Things for TTNP Stock Investors to Know about the JT Pharma Deal